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Front cover image: Like Janus, the Roman god 
with two faces, antioxidants have sometimes 
contrasting properties.  At some concentrations, 
antioxidants are protective, but at other (usually 
higher) concentrations, antioxidants can be pro-
oxidants or even toxic.
Also analogous to the two faces of Janus, 
antioxidants are often highly protective in
pre-clinical settings, but too often fail in
clinical trials in various diseases.
Finally, like Janus, while much is known about 
small molecule antioxidants, much remains to 
be learned of hormesis induced by molecules 
that, though not directly antioxidants, lead to 
induction of protective genes that show promise 
of protection in some disorders. 
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